Gerrards Cross: LSH negotiates deal to bring major US bio-pharmaceutical company to the region
Lambert Smith Hampton (LSH), on behalf of renowned publicly-listed US bio-pharmaceutical company Amicus Therapeutics (Amicus), has secured 9,000 sq ft of grade A office space at Phoenix House, Gerrards Cross, on two protected five-year leases.
The deal allows Amicus to establish a presence in the UK, supporting the company’s other European offices in Munich, Paris, Madrid and Amsterdam. Phoenix House is situated in an excellent strategic location in Gerrard’s Cross, Buckinghamshire, and allows easy access to Junction 1 of the M40, providing a link to Central London and the M25.
Commenting on the deal, Cliff Jackson, director of office agency at LSH’s Maidenhead office, said the move gives Amicus "a great operational platform for today with the flexibility for the future that a company with such exciting plans needs. With assistance from our building consultancy team who managed the fit-out, Phoenix House has provided this and we look forward to assisting this worthy organisation with its success in the future.”
Amicus, whose headquarters are in Cranbury, New Jersey, develops advanced therapies to treat a range of devastating rare diseases, and currently has a robust development pipeline of novel, first-in-class treatments for a broad range of human genetic diseases.
Colliers acted on behalf of the landlord for one of the two leases.
